Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

NCT06756152

Conditions: Acute Lymphoblastic Leukemia, Bilinear Leukemia, Biphenotypic Acute Leukemia, +21 more
Locations: National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov Moscow, Russia

View Trial Details

Recruiting

Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL

NCT06754267

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

NCT06752785

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Guangzhou Medical University Affiliated Women and Children's Medical Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT05958719

Conditions: Epigenetic Repression, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

NCT06342466

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker

NCT05501379

Conditions: Behavior, Colonic Diseases, Colorectal Cancer, +26 more
Locations: University Medicine Greifswald Greifswald, Germany

View Trial Details

Recruiting

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

NCT06690593

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Zhujiang Hospital of Southern Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

Safety and Durability of Sirolimus for Treatment of LAM

NCT02432560

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Stanford University Medical Center Stanford, California, United States

National Jewish Health Denver, Colorado, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Emory University School of Medicine Atlanta, Georgia, United States

View all 20 locations

View Trial Details

Recruiting

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

NCT06082284

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT05967416

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope Duarte, California, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions